Current Portfolio
Aerska
Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain.
The company is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS.)
Key Facts
- Sector
Life Sciences
- Country
Ireland
- Fund
LSP Dementia Fund
- Entry
2025
Website
Responsible Partner
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.